Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions

por Sherburn, Rebekah, Tolbert, William D., Gottumukkala, Suneetha, Hederman, Andrew P., Beaudoin-Bussières, Guillaume, Stanfield-Oakley, Sherry, Tuyishime, Marina, Ferrari, Guido, Finzi, Andrés, Ackerman, Margaret E., Pazgier, Marzena
Publicado 2021

Decoding human-macaque interspecies differences in Fc-effector functions: The structural basis for CD16-dependent effector function in Rhesus macaques

por Tolbert, William D., Gohain, Neelakshi, Kremer, Paul G., Hederman, Andrew P., Nguyen, Dung N., Van, Verna, Sherburn, Rebekah, Lewis, George K., Finzi, Andrés, Pollara, Justin, Ackerman, Margaret E., Barb, Adam W., Pazgier, Marzena
Publicado 2022

SARS-CoV-2 mRNA vaccination elicits broad and potent Fc effector functions to VOCs in vulnerable populations

por Hederman, Andrew P., Natarajan, Harini, Wiener, Joshua A., Wright, Peter F., Bloch, Evan M., Tobian, Aaron A.R., Redd, Andrew D., Blankson, Joel N., Rottenstreich, Amihai, Zarbiv, Gila, Wolf, Dana, Goetghebuer, Tessa, Marchant, Arnaud, Ackerman, Margaret E.
Publicado 2022

SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations

por Hederman, Andrew P., Natarajan, Harini, Heyndrickx, Leo, Ariën, Kevin K., Wiener, Joshua A., Wright, Peter F., Bloch, Evan M., Tobian, Aaron A. R., Redd, Andrew D., Blankson, Joel N., Rottenstreich, Amihai, Zarbiv, Gila, Wolf, Dana, Goetghebuer, Tessa, Marchant, Arnaud, Ackerman, Margaret E.
Publicado 2023

Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike

por Crowley, Andrew R., Natarajan, Harini, Hederman, Andrew P., Bobak, Carly A., Weiner, Joshua A., Wieland-Alter, Wendy, Lee, Jiwon, Bloch, Evan M., Tobian, Aaron A.R., Redd, Andrew D., Blankson, Joel N., Wolf, Dana, Goetghebuer, Tessa, Marchant, Arnaud, Connor, Ruth I., Wright, Peter F., Ackerman, Margaret E.
Publicado 2021

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike

por Crowley, Andrew R, Natarajan, Harini, Hederman, Andrew P, Bobak, Carly A, Weiner, Joshua A, Wieland-Alter, Wendy, Lee, Jiwon, Bloch, Evan M, Tobian, Aaron AR, Redd, Andrew D, Blankson, Joel N, Wolf, Dana, Goetghebuer, Tessa, Marchant, Arnaud, Connor, Ruth I, Wright, Peter F, Ackerman, Margaret E
Publicado 2022

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

por Chen, Yaozong, Sun, Lulu, Ullah, Irfan, Beaudoin-Bussières, Guillaume, Anand, Sai Priya, Hederman, Andrew P., Tolbert, William D., Sherburn, Rebekah, Nguyen, Dung N., Marchitto, Lorie, Ding, Shilei, Wu, Di, Luo, Yuhong, Gottumukkala, Suneetha, Moran, Sean, Kumar, Priti, Piszczek, Grzegorz, Mothes, Walther, Ackerman, Margaret E., Finzi, Andrés, Uchil, Pradeep D., Gonzalez, Frank J., Pazgier, Marzena
Publicado 2021

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

por Chen, Yaozong, Sun, Lulu, Ullah, Irfan, Beaudoin-Bussières, Guillaume, Anand, Sai Priya, Hederman, Andrew P., Tolbert, William D., Sherburn, Rebekah, Nguyen, Dung N., Marchitto, Lorie, Ding, Shilei, Wu, Di, Luo, Yuhong, Gottumukkala, Suneetha, Moran, Sean, Kumar, Priti, Piszczek, Grzegorz, Mothes, Walther, Ackerman, Margaret E., Finzi, Andrés, Uchil, Pradeep D., Gonzalez, Frank J., Pazgier, Marzena
Publicado 2022